Bank of New York Mellon’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.3M Buy
203,632
+72,609
+55% +$7.58M ﹤0.01% 1481
2025
Q1
$15.3M Sell
131,023
-3,527
-3% -$411K ﹤0.01% 1637
2024
Q4
$11.4M Sell
134,550
-1,896
-1% -$160K ﹤0.01% 1857
2024
Q3
$12.3M Sell
136,446
-29,118
-18% -$2.62M ﹤0.01% 1827
2024
Q2
$13.3M Buy
165,564
+11,793
+8% +$949K ﹤0.01% 1810
2024
Q1
$12.3M Sell
153,771
-12,522
-8% -$999K ﹤0.01% 1857
2023
Q4
$13.2M Sell
166,293
-1,713
-1% -$136K ﹤0.01% 1824
2023
Q3
$11.7M Buy
168,006
+6,920
+4% +$484K ﹤0.01% 1850
2023
Q2
$11.6M Buy
161,086
+35,970
+29% +$2.58M ﹤0.01% 1863
2023
Q1
$7.72M Sell
125,116
-3,382
-3% -$209K ﹤0.01% 2063
2022
Q4
$9.91M Sell
128,498
-6,632
-5% -$512K ﹤0.01% 1949
2022
Q3
$6.03M Buy
135,130
+17,720
+15% +$791K ﹤0.01% 2189
2022
Q2
$4.5M Buy
117,410
+11,987
+11% +$459K ﹤0.01% 2373
2022
Q1
$4.36M Sell
105,423
-16,556
-14% -$685K ﹤0.01% 2497
2021
Q4
$4.61M Sell
121,979
-24,427
-17% -$923K ﹤0.01% 2504
2021
Q3
$4.83M Buy
146,406
+8,107
+6% +$267K ﹤0.01% 2505
2021
Q2
$9.33M Sell
138,299
-6,675
-5% -$450K ﹤0.01% 2175
2021
Q1
$8.21M Sell
144,974
-5,445
-4% -$308K ﹤0.01% 2201
2020
Q4
$12.3M Buy
150,419
+1,860
+1% +$152K ﹤0.01% 1900
2020
Q3
$10.6M Buy
148,559
+1,520
+1% +$108K ﹤0.01% 1825
2020
Q2
$12.1M Sell
147,039
-6,142
-4% -$505K ﹤0.01% 1722
2020
Q1
$9.01M Buy
153,181
+6,556
+4% +$386K ﹤0.01% 1755
2019
Q4
$15.2M Sell
146,625
-17,826
-11% -$1.84M ﹤0.01% 1733
2019
Q3
$3.33M Buy
164,451
+55
+0% +$1.11K ﹤0.01% 2473
2019
Q2
$4.23M Buy
164,396
+76,555
+87% +$1.97M ﹤0.01% 2416
2019
Q1
$1.25M Buy
87,841
+53,151
+153% +$756K ﹤0.01% 3029
2018
Q4
$98K Buy
+34,690
New +$98K ﹤0.01% 3955
2017
Q2
Sell
-22,723
Closed -$88K 4298
2017
Q1
$88K Sell
22,723
-8,195
-27% -$31.7K ﹤0.01% 4050
2016
Q4
$208K Buy
30,918
+9,564
+45% +$64.3K ﹤0.01% 3892
2016
Q3
$169K Hold
21,354
﹤0.01% 3930
2016
Q2
$161K Buy
+21,354
New +$161K ﹤0.01% 3955
2016
Q1
Sell
-11,512
Closed -$107K 4210
2015
Q4
$107K Buy
+11,512
New +$107K ﹤0.01% 4015